Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

DSGNDSGN
7 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in DESIGN THERAPEUTICS INC

Qube Research & Technologies Ltd holds 437,079 shares of DSGN (DESIGN THERAPEUTICS INC), worth $6.3M as of 2026-Q2. The position was increased (+1178.6% shares). DSGN represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$6.3M

Current Shares

437,079

Total Value Change

+$5.8M

Total Shares Change

+414,027

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
437,079
+1178.6%
$6.3M0.0%$14.47
44
2026-Q1
New
34,183
-
$363,7070.0%$10.00
33
2024-Q3
Exited
0
-100.0%
$00.0%$5.33
0
2024-Q2
New
2,986
-
$10,0030.0%$3.35
26
2022-Q2
Exited
0
-100.0%
$00.0%$14.02
0
2022-Q1
Decreased
20,396
-11.5%
$329,0000.0%$16.01
0
2021-Q4
New
23,052
-
$494,0000.0%$21.29
33

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used